Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB25FNVQF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,847
Award facts
- Contract value 100% obligated
- $13,846.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for VYNDAMAX 61 mg capsule unit dose packages (30-count). This firm fixed-price contract, awarded on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive delivery order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. VYNDAMAX (tafamidis) is a specialty pharmaceutical used primarily for the treatment of transthyretin amyloid cardiomyopathy, reflecting the Defense Logistics Agency's procurement of specialty medications to support military healthcare systems.
This delivery order is executed under AmerisourceBergen's existing $999.99 billion IDC with DLA Troop Support Medical (contract SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated substantial capability in fulfilling federal medical supply requirements through open competition. The company's role as a prime vendor reflects its critical position in supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a diverse portfolio of brand-name and generic pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FNVQF?
SPE2DB25FNVQF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FNVQF worth?
The government has obligated $13,847 on SPE2DB25FNVQF.
Is contract SPE2DB25FNVQF an order under another contract?
Yes. SPE2DB25FNVQF is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNVQF competed?
The extent of competition for SPE2DB25FNVQF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award